Based on the PetIQ Inc stock forecast from 1 analysts, the average analyst target price for PetIQ Inc is USD 30.00 over the next 12 months. PetIQ Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of PetIQ Inc is Slightly Bullish , which is based on 6 positive signals and 5 negative signals. At the last closing, PetIQ Inc’s stock price was USD 30.98. PetIQ Inc’s stock price has changed by +0.00% over the past week, +0.23% over the past month and +69.29% over the last year.
No recent analyst target price found for PetIQ Inc
No recent average analyst rating found for PetIQ Inc
Company Overview PetIQ Inc
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho. As of October 25, 2024, PetIQ, Inc. was taken private. Read Less
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabe...Read More
Frequently Asked Questions About PetIQ Inc (PETQ) Stock
Based on ratings from 1 analysts PetIQ Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on PETQ's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for PETQ is USD 30.00 over the next 12 months. The maximum analyst target price is USD 30 while the minimum anlayst target price is USD 30.
PETQ stock's Price/Earning ratio is 83.73.
Our analysis grades PETQ stock's Price / Earning ratio at F. This means that PETQ stock's Price/Earning ratio is above 81% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSD exchange.
Based on this PETQ may be a overvalued for its sector.
The last closing price of PETQ's stock was USD 30.98.
The most recent market capitalization for PETQ is USD 0.93B.
Based on targets from 1 analysts, the average taret price for PETQ is projected at USD 30.00 over the next 12 months.
This means that PETQ's stock price may go down by -3.16% over the next 12 months.
We can't find any ETFs which contains PetIQ Inc's stock.
As per our most recent records PetIQ Inc has 1,121 Employees.
PetIQ Inc's registered address is 230 East Riverside Drive, Eagle, ID, United States, 83616.
You can get more information about it from PetIQ Inc's website at https://petiq.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About PetIQ Inc (PETQ) Stock
Based on ratings from 1 analysts PetIQ Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on PETQ's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for PETQ is USD 30.00 over the next 12 months. The maximum analyst target price is USD 30 while the minimum anlayst target price is USD 30.
PETQ stock's Price/Earning ratio is 83.73.
Our analysis grades PETQ stock's Price / Earning ratio at F. This means that PETQ stock's Price/Earning ratio is above 81% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSD exchange.
Based on this PETQ may be a overvalued for its sector.
The last closing price of PETQ's stock was USD 30.98.
The most recent market capitalization for PETQ is USD 0.93B.
Based on targets from 1 analysts, the average taret price for PETQ is projected at USD 30.00 over the next 12 months.
This means that PETQ's stock price may go down by -3.16% over the next 12 months.
We can't find any ETFs which contains PetIQ Inc's stock.
As per our most recent records PetIQ Inc has 1,121 Employees.
PetIQ Inc's registered address is 230 East Riverside Drive, Eagle, ID, United States, 83616.
You can get more information about it from PetIQ Inc's website at https://petiq.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for PETQ !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
